Skip to content

XTI Aerospace, Inc. XTIA ADS — Other Research And Development Expense

Other segment segments

UAS
$48K

Similar metrics at other companies

Disc Medicine logo
IRONOther Research — Research And Development Expense
$2.17M+18.2%
Aquestive Therapeutics, Inc. logo
AQSTOther — R&D
$319K-41.6%
MapLight Therapeutics, Inc.
 logo
MPLTAll Other Segments — Research And Development Expense
$933K+22.6%
CTO
CTOROther Research And Development Expense
$469K-2.3%
OS Therapies logo
OSTXOther Research And Development Expense
$0
Resideo Technologies, Inc. logo
REZIADI Global Distribution — Research and development expenses
$12M+50.0%

Other financials

Income statement

See full
Revenue$27.7M+5,622%
Gross profit$5.1M+1,436%
Operating income-$10.4M-26.7%
Net income-$35.3M-174%
EPS (diluted)-$1.00+73.7%

Balance sheet

See full
Cash & equivalents$15.2M+89.6%
Total debt$22.8M+14,541%
Total equity-$26.6M-291%
Total assets$78.3M+189%

Cash flow

See full
Operating cash flow-$10.5M+31.4%
CapEx$131.0K+191%
Free cash flow-$10.6M+30.8%

Valuation

See full
Market cap$69.64M+136%
Enterprise value$77.3M+970%
P/S1.4×-8.3×

Profitability

See full
Gross margin19.6%-40.5pp
Operating margin-86.1%-40.7pp
Net margin-183.4%-84.9pp
FCF margin-64.6%-31.3pp

Returns & leverage

See full
Return on equity-565.7%
Debt / equity1.1×+0.6×
Current ratio0.6×-0.4×

Where this comes from

Reported directly by XTI Aerospace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The official record: XTI Aerospace, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about XTI Aerospace, Inc.'s ads — other research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XTI Aerospace, Inc.'s ADS — other research and development expense?
XTI Aerospace, Inc. (XTIA) reported ADS — other research and development expense of $1.15M in Q1 2026.
What does ADS — other research and development expense mean?
This metric represents miscellaneous research and development costs incurred by the ADS business segment that are not classified under primary R&D categories. It captures secondary innovation-related expenditures necessary to support the segment's product development lifecycle. Monitoring these costs helps investors understand the secondary investment intensity required to maintain the segment's competitive technological edge.